Immunogenicity, efficacy and safety of the three-valent inactivated influenza split vaccine in patients with ankylosing spondylitis and psoriatic arthritis

According to the World Health Organization (WHO), worldwide, annual influenza epidemics lead to approximately 3–5 million cases of severe forms of the disease and 250–500 thousand deaths. The problem of the course and outcomes of influenza is also relevant for patients with immunoinflammatory rheuma...

Full description

Bibliographic Details
Main Authors: M. M. Baranova, N. V. Muravyeva, B. S. Belov, M. E. Diatroptov
Format: Article
Language:Russian
Published: IMA PRESS LLC 2024-06-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/3577